The present study investigated the possibility that macrophage colony-stimulating factor (M-CSF) responsiveness of hematopoietic progenitor cells is regulated at the level of receptor expression and that M-CSF receptor (M-CSFR) may be used as an early marker of monocyte lineage commitment. Immunofluorescence measurements with an anti-M-CSFR antibody showed that 44% * 5% of CD34h' cells expressed the receptor. The M-CSFR was present on progenitor cells that were positive for the granulo-monocytic marker CD64, but not on primitive, erythroid, or lymphoid progenitors. The CD34h'CD64+ population could be divided into subsets of M-CSFRh' and M-CSFR'" cells. In addition, a subset of CD34h'CD64-M-CSFRhi cells was found. CD34+ cells that were positive for M-CSFR, CD64, or both gave rise exclusively to granulo-monocytic cells, and 65% of the granulomonocytic colony-forming cells in the CD34' population were recovered from these cells. Approximately 70% of the colony-forming cells (CFCs) derived from CD34h'M-CSFRh' cells were macrophage colony-forming units (CFU-M), URING EARLY hematopoietic development, multipo-D tent stem cells proliferate and differentiate into lineage-committed progenitors. This process is currently poorly understood, and it is not known how differentiation and proliferation are regulated by extracellular factors. However, the ability to influence these events is critical for ex vivo expansion and manipulation of hematopoietic progenitor cells. A better understanding of the early steps of hematopoiesis depends on a more precise definition of progenitor cell types as well as knowledge about molecules that are regulated during the transition from one stage of maturation to the next.
D tent stem cells proliferate and differentiate into lineage-committed progenitors. This process is currently poorly understood, and it is not known how differentiation and proliferation are regulated by extracellular factors. However, the ability to influence these events is critical for ex vivo expansion and manipulation of hematopoietic progenitor cells. A better understanding of the early steps of hematopoiesis depends on a more precise definition of progenitor cell types as well as knowledge about molecules that are regulated during the transition from one stage of maturation to the next.
Subsets of hematopoietic progenitor cells respond differently to a large number of cytokines.' For certain cytokines, differences in cellular responsiveness have been ascribed to changes in receptor expression during early progenitor cell
We have recently shown that the receptor for erythropoietin (EPO-R) is specifically expressed on cells that have undergone commitment to the erythroid lineage. 3 This finding shows that the receptor for a lineage-restricted cytokine may serve as an early marker of progenitor cell commitment. Macrophage colony-stimulating factor (M-CSF) is another cytokine with highly selective a~tivity.~ Injection of M-CSF into nonhuman primates leads to an increase in the number of monocytes in peripheral blood, whereas no changes are observed in the number of other myeloid cells.5 Colonies formed when bone marrow (BM) cells are cultured in the presence of M-CSF alone contain predominantly monocytic cells.6-8 When added in combination with other cytokines, M-CSF stimulates the formation of colonies from high proliferative potential colony-forming cells (HPP-CFCS).~." This may indicate that the ability to respond to M-CSF is an early event in myeloid development. If M-CSF responsiveness is determined by receptor expression in a similar way as shown for EPO, the M-CSF receptor (M-CSFR) represents a candidate for an early marker of whereas 91% of the CFCs in the CD34h'CD64+M-CSFR'o population were granulocyte colony-forming units (CFU-G). The M-CSFRh' cells with the highest frequency of colony-forming and bipotent cells and largest average colony size were found in the CD64-subset, indicating that M-CSFR appears earlier than CD64 during monocyte development. After 60 hours in culture, a subset of the CD34h'M-CSFRh' cells had downmodulated M-CSFR (29% to 38%). This population gave rise almost exclusively to granulocytes, whereas the cells that remained M-CSFRh' gave rise exclusively to monocytes. In all experiments, the M-CSFRh' population responded to M-CSF, whereas minimal responses were observed among M-CSFR'" cells. These results suggest that M-CSF target specificity among human hematopoietic progenitor cells is determined by lineage-specific regulation of the M-CSFR and show that M-CSFR is a useful marker to discriminate between monocytic and granulocytic progenitor cells. 0 1996 by The American Society of Hematology.
monocyte lineage commitment. The M-CSFR would be a particularly informative differentiation marker because its expression depends on the PU.l transcription factor, which plays important roles in hematopoietic devel~pment.'~''~ We have recently shown that another PU. 1 -regulated molecule, CD64, appears at an early stage in granulo-monocytic differentiation, when the cells express high levels of the CD34 antigen. 3 .16 The present study investigated the possibility that M-CSF responsiveness and M-CSFR expression may be used to discriminate monocytic and granulocytic cells within the CD34h' population. Phenotypically and functionally defined CD34+ subsets were stained with anti-M-CSFR monoclonal antibodies (MoAbs) to measure expression on primitive progenitors and cells committed to the granulomonocytic, erythroid, and lymphoid lineages. Cells with different levels of the M-CSFR and early lineage markers were then sorted and assayed for M-CSF responsiveness, colonyforming ability, and in vitro differentiation. The results show that the M-CSFR is expressed on 44% 5 5% of CD34hi cells. These cells corresponded to the M-CSF-responsive fraction of CD34h' cells. CD34h'M-CSFRhi cells were highly clonogenic and approximately 70% of the colony-forming cells
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(CFCs) were macrophage colony-forming units (CFU-M), whereas less than 20% were granulocyte colony-fonning units (CFU-G). In contrast, CD34hi cells that were positive for the granulo-monocytic marker CD64 and negative for the M-CSFR contained high frequencies of 91% pure CFU-G. After 60 hours in culture, CD34h'M-CSFRhi cells developed into distinct populations of M-CSFRhi and M-CSFR'" cells. These two populations gave rise almost exclusively to monocytes and granulocytes, respectively. These results suggest that M-CSF target specificity among human hematopoietic progenitor cells is determined by lineage-specific regulation of the M-CSFR and show that M-CSFR is a useful marker to discriminate CFU-M from CFU-G. The serum-free medium consisted of Iscove's modified Dulbeccos medium with 25 mmol/L HEPES buffer (Sigma Chemical Co, St Louis, MO) supplemented with 200 pg/mL iron-saturated transferrin (ICN Biomedicals, Inc, Costa Mesa, CA), 2% bovine serum albumine (Sigma), 5 X IO-' mom 2-mercaptoethanol, and penicillin and streptomycin at 100 U/mL and 100 pg/mL, respectively (JRH Biosciences, Lenexa, KS)." Right before use, 50 pg/mL human low-density lipoprotein (LDL; Sigma) was added to this medium.'" For studies with serum-containing medium, 20% heat-inactivated fetal bovine serum (FBS; Sigma) was added instead of LDL. Recombinant human interleukin-3 (rhIL-3), rhIL-6, and recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) were from Collaborative Biomedical Products (Bedford, MA). Recombiant human stem cell factor (rhSCF) was from Peprotech (Rocky Hill, NJ), recombinant human macrophage colony-stimulating factor (M-CSF) was from R&D Systems (Minne-
MATERIALS AND METHODS
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Cytokines and media.
apolis, MN), recombinant human EPO (rhEP0) was from ClLAG AG (Schaffhausen, Switzerland), and recombinant human granulocyte-CSF (rhG-CSF) was from Amgen (Thousand Oaks, CA). Cytokines were added at final concentrations of IO ng/mL rhGM-CSF, IO ng/mL rhIL-3, 500 U/mL rhIL-6, 40 ng/mL rhSCF, 50 ng/mL rhG-CSF, 10 ng/mL rhM-CSF. and 2.5 U/mL rhEpo.
Human BM from aborted fetuses of gestational age 17 to 22 weeks was obtained from Advanced Bioscience Resources (Alameda, CA) and The Anatomic Gift Foundation (Folkston, GA), both nonprofit corporations, which provide tissue in compliance with state and federal laws. The intramedullary cavities of upper and lower extremity bones were flushed with phosphate-buffered saline-fetal calf serum (PBS-FCS), and the cell suspension was centrifuged. The cell pellet was resuspended in PBS-FCS. Human adult BM from healthy donors was generously provided by Dr Ping Law (Stem Cell Laboratories, Division of Hematology and Oncology, University of California San Diego, San Diego, CA). Adult BM and cell suspensions from fetal BM (FBM) was diluted IO-fold in a solution containing 0.9% NH,Cl, 0.1% KHCOz, and 0.0037% tetrasodium EDTA in double-distilled H 2 0 (pH 7.2, 20°C) to lyse mature red blood cells. After 5 minutes of lysing, cells were centrifuged, washed twice in PBS-FCS, and filtered through a 70-pm nylon filter (Becton Dickinson Labware, Franklin Lakes, NJ) for subsequent staining.
To minimize nonspecific antibody binding, cells were preincubated with PBS containing 0.5% human gamma globulin (Sigma). For indirect immunofluorescence staining, nucleated BM cells were incubated with an unlabeled MoAb, washed twice in PBS-FCS, and stained with fluorochrome-conjugated secondary antibodies. All incubation steps were performed on ice for 25 minutes. Immunostained cells were either kept on ice and analyzed immediately by flow cytometry or fixed in 0.5% paraformaldehyde and analyzed within 24 hours.
Flow cytometric analysis. Immunostained cells were analyzed using an experimental high-sensitivity flow cytometer designed by Dr Robert Hoffman (BDIS). This flow cytometer is equipped with three lasers: a 488-nm Argon Ion laser (15 mW) for excitation of PerCP and FITC, a 633-nm Helium-Neon laser ( I O mW) for excitation of APC or Cy5, and a 532-nm YAG laser (20 mW) for excitation of PE. The 532-nm excitation of PE yields six times the signal-tonoise ratio obtained with 488-nm excitation (data not shown). For each sample, 10,000 to 50,000 events were acquired in list mode with Cell Quest software (BDIS). Forward light scatter, orthogonal light scatter, and four fluorescence signals were determined for each cell, and the listmode data files were analyzed on a Macintosh cornputer with Paint-A-GatePRo (BDIS). The instrument was calibrated using fluorescent particles to allow direct comparison between staining intensities measured in different experiments. Dead cells were identified by positive staining with propidium iodide (PI; Molecular Probes Inc, Eugene, OR) at a final concentration of 1 pg/mL.
Before cell sorting, CD34' cells were purified from nucleated BM cells using a separation kit from Miltenyi Biotech (Auburn, CA) according to the description from the manufacturer. The purification method routinely gave CD34' cells that were more than 90% pure and the yield was typically 70% to 80% (results not shown). Purified cells were then stained with CD34 FITC (HPCA-2; BDIS) and fluorochrome-or biotin-conjugated MoAbs to other antigens to allow flow cytometric sorting of progenitor cell subsets.
Measurement of Bromodeoxyuridine (BrdU) incorporation. Immunomagnetically purified CD34' cells were cultured for 24 hours in serum-free (SF) medium only, followed by 24 hours of culture with or without the addition of 40 ng/mL SCF or 10 ng/mL M-CSF. BrdU (Sigma) was added to the culture for the last 6 hours Cell separation.
Cell staining.
Immunomagnetic purijcarion of CD34' cells.
For personal use only. on November 11, 2017. by guest www.bloodjournal.org From at a final concentration of 60 pmol/L. After the culture period, the cells were washed twice in PBS-FCS, stained with CD34 APC and CD64 PE, and fixed in 0.5% paraformaldehyde (100 pL/sample) at 4°C. After 4 hours, 22 pL PBS containing 5% Tween 20 (Sigma) was added and the cells were incubated for 12 additional hours at 4°C. The cells were then washed twice in PBS. Twenty microliters of PBS containing 10 mg/mL DNAse I (Sigma catalogue no. DN-25) and 4 pg/mL anti-BrdU FlTC MoAb (BDIS) was added to the cell pellets. The cells were incubated for a minimum of 1 hour at room temperature followed by the addition of 200 pL PBS before the samples were analyzed on the flow cytometer.
Immunostained cells were sorted by a FACS Vantage flow cytometer equipped with an Automated Cell Deposition Unit (Becton Dickinson Immunocytometry Systems, San Jose, CA). FITC and PE fluorescence was excited by a 488-nm argon ion laser and APC or Cy5 fluorescence by a 90-mW Specl" laser tuned at 647 nm. To eliminate doublets and cell aggregates, a pulse processor module was used on the forward light scatter parameter. The gates defining cells staining positively with MoAbs were set to include less than 2% of cells stained with isotype control. For determination of colony-forming potential, cells were sorted singly into 96-well plates (Falcon Labware) containing serum-supplemented medium and the concentrations of SCF, IL-3, IL-6, GM-CSF, G-CSF, M-CSF, and EPO described above. For determination of cytokine effects on populations, each cell subset was sorted into polypropylene tubes containing the SF medium described above. The cells were then equally distributed between individual wells in a 24-well plate (Becton Dickinson Labware, Franklin Lakes, NJ) and serum and cytokines were added as indicated at the concentrations described above.
Ninety-six-well plates containing singly sorted cells were examined for the presence of progeny after 14 days of culture by examination through an inverted light microscope. The colonies were initially classified in four categories according to size. A type I colony had 40 to 100 cells. For colony types I1 through IV, colony sizes were compared with cell numbers by counting cells from individual colonies by flow cytometry using a fixed number of fluorescent latex beads as standards:' as described earlier.3 A type I1 colony had more than 100 cells, but covering less than 25% of the area of the well (average cell number, 1,871; range, 102 to 10,595; n = 48). A type 111 colony had cells covering 25% to 50% of the area of the well (average cell number, 41,924; range, 5,162 to 84,483; n = 32). A type IV colony had cells covered more than 50% of the area in the well (average cell number, 316,640; range, 80,593 to 823,034; n = 26). The cellular content of individual colonies was determined by staining each colony with CD14 FITC, CD15 PE, CD71 PerCP, and CD48 APC and the nonvital DNA dye PI, followed by four-color flow cytometric analysis. CD14 is expressed on monocytic ~e l l s :~.~~ and CD15 is upregulated during myeloid differentiation and is primarily expressed on granulocytic cells.24 CD71 is highly expressed, although not specific for, erythroid cells,"'.2s and CD48 is a leukocyte-specific marker.3.z6 The combination of these four markers allows the specific identification of granulocytic, monocytic, and erythroid cell subsets. Granulocytic and monocytic cells were both classified as CD48' and CD71'".3,'6 Neutrophilic granulocytes were further identified as CD 14-CD I 5h' and basophilic granulocytes as CD14-CD 15msd'um, whereas monocytic cells were classified as CD14h'CD15'o (see Fig 3) .'.16 Erythroid cells were characterized as CD14-CD15'°CD48'0CD71h'.3~'6 Colonies containing less than 300 cells were pooled according to their growth pattern as macrophages, granulocytic cells, or erythroid cells and analyzed by flow cytometry. The flow cytometric classificaton was validated by Wright Giemsa staining of selected colonies (data not shown).
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RESULTS
M-CSF induces expansion of granulo-monocytic but not
primitive and erythroid progenitors during 5 days of culture. CD34' subsets previously shown to be highly enriched for primitive, erythroid, and granulo-monocytic progenitors were sorted and cultured to determine whether M-CSF acted differently on the cell types. The population identified as CD34" in the present study was set to include, on average, 15.7% ? 1.5% of the CD34+ cells (n = 4). Primitive hematopoietic progenitors were defined as CD34hiCD3810CD50+ (regions 1, 3, and 4 in Fig l) .3,27*28 CD50 was used to discriminate hematopoietic cells from CD34hiCD38'0 stromal progenitor cells." CD64 is specifically expressed by cells committed to the granulo-monocytic lineage, and granulomonocytic progenitors were defined as CD34'%D64+CD7 1'" (regions 1, 3, and 5 in Fig l) .3.16 Erythroid progenitors were defined as CD341"CD64-CD71hi (regions 2, 3, and 6 in Fig  l) .3,20 Cells were harvested after 5 days of culture, counted, and stained with CD14,22,23 CD15," CD48:6 and CD71,2°.25 which allow discrimination between differentiated neutrophilic granulocytes, basophilic granulocytes, and monocytic and erythroid cells,I6 as described in the Materials and Methods. The addition of M-CSF to the medium did not increase the number of viable progeny from primitive progenitors (CD34hiCD3810CD50') or erythroid progenitors (CD34'"CD-64-CD71h'; Fig 2) . This was not due to lack of factors necessary for promoting cell survival, because M-CSF did not increase proliferation significantly in the presence of SCF (Fig 2) . Both progenitor types proliferated extensively when cultured in medium containing serum and SCF, IL-3, IL-6, GM-CSF, G-CSF, M-CSF, and Epo (hereafter called FBS + S,3,6,GM,G,M,E), showing that the cells were not damaged by the cell sorting (Fig 2) . Granulo-monocytic progenitors (CD34h'CD64+CD7110) proliferated extensively (19.5-? 2.9-fold; n = 4) in the presence of M-CSF. M-CSF induced 5.5-fold higher expansion of the CD34h'CD64+ cells than did SCF (P = .OOOl; n = 4), and the two factors did not act synergistically to induce proliferation of this subset.
CD34+CD64+ cells give rise to neutrophilic granulocytes, basophilic granulocytes, and monocytes after 5 to 7 days of culture.16 These populations can be discriminated as distinct subsets by the combined measurement of CD14 and CD15 (Fig 3) .16 Cells cultured in the presence of FBS + S,3,6,GM,G,M,E gave rise to 42% f 7.5% granulocytic cells and 58% t 3.1% monocytic cells (n = 4; Fig 3) . In contrast, 91% t 2.8% (n = 4) of the cells formed in the presence of M-CSF alone were monocytic (Fig 3) . M-CSF alone induced on average 45% of the expansion of monocytic cells observed in the optimized medium, but, on average, only 6% of the expansion of granulocytic cells. These results suggest that M-CSF acts specifically on progenitors committed to the granulo-monocytic lineage and predominantly promotes the outgrowth of monocytes from these cells. M-CSF is a stronger mitotic stimulus for granulo-monocytic progenitor cells than SCF. M-CSF induced a significantly higher expansion than SCF of the granulo-monocytic CD34"CD64+ cells during 5 days in culture (Fig 2) . To 
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exclude that this was due to differentiation-associated regulation of the receptors, we measured the proliferation induced by M-CSF and SCF directly in CD34'CD64+ cells after 24 hours in culture with M-CSF or SCF. Cells enriched for CD34' progenitors were starved for growth factors by incubation in serum-free medium for 24 hours and then incubated for an additional 24 hours in medium only (Fig 4A) or with the addition of 40 ng/mL SCF (Fig 4B) or IO ng/mL M-CSF (Fig 4C) . For the last 6 hours, BrdU was added to the medium. The cells were then stained with CD34, CD64, and anti-BrdU, as described in the Materials and Methods. The results showed that M-CSF induced a 3-to 3.2-fold (n = 2) increase in the number of CD34TD64' cells incorporating BrdU relative to medium alone, whereas SCF only induced a 1.4-to 1.7-fold increase (n = 2). No anti-BrdU-positive cells were detected in controls that were incubated without BrdU (data not shown). No significant expansion for the total cell population could be detected after the 24 hours of incubation with cytokines (results not shown). These data indicate that the stronger mitotic stimulus induced by M-CSF as compared with SCF in granulo-monocytic progenitor cells is a direct effect.
M-CSFR i s expressed on granulo-monocytic progenitors
but not on primitive, erythroid, and lymphoid progenitors. M-CSFR expression was correlated to the responsiveness of cells to M-CSF by staining cells with MoAbs to the M-CSFR (3-4A4). CD34, and the markers used for cell sorting shown in Fig 1. Anti-M-CSFR MoAbs stained freshly isolated CD34" cells weakly (data not shown). However, after overnight incubation of the cells in SF medium, on average 44% 2 5% (n = 3) of the CD34h' cells were positive for the M-CSFR (Fig 5A) . The populations enriched for primitive (CD34"CD38'"CD50') and erythroid progenitor cells (CD34'"CD64CD7 1 hi) are shown as enlarged black dots in Fig 5C and D, respectively. These cells did not stain more brightly with anti-M-CSFR than with isotype control MoAbs. Granulo-monocytic progenitors (CD34h'CD64+ CD7 1'") stained heterogeneously with anti-M-CSFR MoAbs (Fig 5E) . In addition, a subset of CD34TD64-M-CSFR' cells was observed (Fig 5E) . B-lymphoid progenitors (CD34TD19') stained with similar intensities with anti-M-CSFR as with isotype control MoAbs (data not shown). The staining of adult BM CD34' cells was highly similar to that observed for FBM cells (data not shown; n = 3).
Incubation of BM cells with M-CSF resulted in a 70% reduction in staining with the anti-M-CSFR MoAb (data not shown).
M-CSFR expression correlates to M-CSF responsiveness.
CD34h' cells are enriched in clonogenic progenitor cells," and CD64 represents the earliest granulo-monocytic marker described for this subset.'" We next investigated whether CD34h' cells with different levels of CD64 and M-CSFR contained different types of granulo-monocytic progenitors. The CD34h' cells (within the region in Fig 6A) were sorted as four populations according to the regions in Fig 6B. These were CD64-M-CSFR'" (48.9% 2 4.8%; n = 4). CD64-MCSFRh' (14.0% 2 3.1%; n = 4). CD64'M-CSFRh' (20.1% 2 1.6%; n = 4), and CD64'M-CSFR'" (7. I % 2 2.6%; n =
Sorted cell population
CD34hiCD38'oCD50+
CD341oCD64-CD71 hi Fig 6B) . To simplify the interpretation of the data, sort regions were set apart to exclude cells with intermediate M-CSFR levels (9.9% t 3.4% of CD34h' cells). The cells that expressed M-CSFR but not CD64 (upper left region in Fig  6B) had 21% t 4% and 33% 2 9% higher levels of CD34 than did the CD64+M-CSFRhi (upper right region) and CD64'M-CSFR'" subsets (lower right region), respectively (P < .006; n = 4). The M-CSFRhi cells lacking CD64 may therefore represent earlier progenitor cells than those expressing CD64.
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After 5 days in culture, the progeny was counted and the cellular content was determined by staining with CD14, CD15, CD48, and CD71, as described in the Materials and Methods. M-CSF responsiveness correlated well with receptor expression, although M-CSF induced a small increase in the number of monocytes obtained from CD64'M-CSFR'" cells (Fig 7) . Furthermore, there was a clear difference in the relative number of monocytes and granulocytes obtained after culture of the subsets with FBS + S,3,6,GM,G,M,E.
The population that was negative both for CD64 and M-CSFR gave rise to similar amounts of monocytes and granulocytes and also to erythroid cells (Fig 7) . The three other populations gave rise exclusively to granulo-monocytic progeny. The majority of cells obtained from the two MCSFRh' populations was monocytic (75% 2 3% and 83% 2 6%, respectively; n = 3), whereas 91% 2 3% of the cells from the CD64'M-CSFR'" population were granulocytes (n = 3). These results show that M-CSFR expression is different on granulocytic and monocytic progenitor cells. Among the M-CSFRh' cells, there was a clear difference in the expansion potential of the subsets that were positive or negative for CD64. The two populations showed a similar expansion in the presence of M-CSF alone. However, the addition of serum and multiple cytokines led to a sixfold increase in the expansion of the CD64-M-CSFRh' cells (P = .003; n = 3), but led to no significant increase in the expansion of the CD64'M-CSFRh' cells. Likewise, monocytic cells derived from the CD64'M-CSFR'" population were maximally expanded by M-CSF alone (Fig 7) . These results further suggest that CD64' monocytic progenitors are more differentiated than those in the CD64-M-CSFRh' population.
CD34h' subsets defined by differential expression of CD64 and M-CSFR contain distinct types qf colony-forming cells. The colony-forming potential of the four CD34h' populations in Fig 6B was examined by single-cell sorting and phenotypic analysis of day-14 progeny as described in the Materials and Methods. The CD34h'CD64-M-CSFR'" population ( Fig 6B) was the only subset containing cells forming mixed and erythroid colonies. This subset also gave rise to the highest fraction of large colonies, as 61 % +. 7% of the colo- nies covered 25% or more of the well (ie, type 111 and IV colonies, see the Materials and Methods). The three subsets expressing either M-CSFR or CD64 or both formed exclusively granulo-monocytic colonies ( Table 1) . Both of the MCSFRh' subsets formed colonies of which more than 80% contained monocytic cells and approximately 70% were CFU-M (n = 3). The highest cloning frequency and frequency of bipotent colonies was observed for the CD64-fraction. Furthermore, of the colonies formed by the CD64-M-CSFRh' cells, 18% ? 9% covered more than 25% of the well, whereas only 7% ? 5% of the colonies from the CD64'M-CSFRhi were of this size. The CD64'M-CSFR'" subset consisted almost entirely of granulocytic progenitors (90.9% ? 3.1%; n = 3), and 36% ? 11% of these colonies covered more than 25% of the well. These results show that CFU-M and CFU-G can be discriminated by combined measurement of CD34, CD64, and the M-CSFR.
Interestingly, almost all the CFU-M and CFU-GM from the CD34' cells could be recovered from the CD34h' cells (Table 2 ). In contrast, only 5 1 % of the CFU-G were derived from the CD34h' fraction ( Table 2) . Nearly all of the remaining CFU-G, as well as all the remaining CFU-M and CFU-GM, were recovered from the CD34'"CD64' fraction (data not shown). The percentage of granulo-monocytic colonies from CD34' cells that could be recovered from cells expressing CD64, M-CSFR, or both was calculated by comparing the frequencies of colony-forming cells in these populations to that of the whole CD34' population. In three experiments, 64.9% ? 4.5% of the granulo-monocytic colonies were recovered from the purely granulo-monocytic CD34TD64' and/or M-CSFR' fractions.
Granulocytic differentiation of CD34"'M-CSFR"' cells is associated with rapid downmodulation of the M-CSFR.
The presence of granulocytic progenitors within the CD34h'M-CSFRhi populations suggested that the relationship between M-CSFR expression and monocyte lineage commitment is not absolute during early hematopoietic differentiation. We therefore investigated the possibility that the recep- Anti-BrdU FITC tor may be regulated in a lineage-dependent way during the subsequent stages of differentiation. Sorted CD34hiM-CSFRh' cells (Fig SA, upper region) were stained with MoAbs to CD34, CD64, and M-CSFR after 60 hours of culture in SF medium containing SCF, IL-3, IL-6, GM-CSF, and G-CSF. As shown in Fig SB, the large majority of the cells expressed relatively high levels of CD64 after the culture. In addition, distinct subsets of M-CSFRh' (62% to 71%; n = 2) and M-CSFR'" cells (38% to 29%; n = 2) could be discriminated. These subsets were sorted and cultured for an additional 5 days. Combined staining of the progeny with CD14 and CD15 showed that the M-CSFRh' subset ( Fig Table 1 , the CD34hiCD64+M-CSFR'" population contained minor fractions of M-CSF-responsive monocytic cells. We therefore examined whether subsets of cells in this population (Fig 8A, lower right region) upregulated the M-CSFR during culture. Sorted CD34hiCD64+M-CSFR'" cells were cultured for 60 hours and stained with CD34, CD64, and anti-M-CSFR. Figure SC shows that a small subset of M-CSFRhi cells (4% to 8%; n = 2) was observed. These cells gave rise to almost exclusively monocytic progeny, whereas the cells that remained M-CSFR'" gave rise to granulocytes. The data correspond well with the results showing that 9% of the clonogenic CD64'M-CSFR'" cells generated monocytic progenitor cells ( Table 1 ) and suggest that monocytic differentiation of these cells is associated with rapid upmodulation of the M-CSFR. CSFRhi (upper region). Nearly all the cells that upregulated the receptor gave rise to monocytic progeny, whereas 80% of the cells generated from the CD64'M-CSFR'" subset were granulocytic. These results may suggest that the upregulation of M-CSFR early in granulo-monocytic differentiation depends on factors that are present in the normal hematopoietic environment, but absent under the culture conditions used here. By day 3, the majority of the cells remained CD64-M-CSFR'" (lower left region, Fig 8D) and gave rise to a mixture of granulocytic, monocytic, and erythroid cells in secondary culture.
Regulation of CD34 during differentiation of CD34"' subsets in vitro. After 60 hours of culture, the cells originating from the CD34h'M-CSFRh' and CD34h'CD64+M-CSFR'" populations shown in Fig 8A were still CD34' (dashed and solid thin lines. respectively. in Fig 9) . However, these cells expressed homogeneously lower levels of CD34 than at day 0 of culture, represented by the vertical line in Fig 9. In contrast, the cells originating from the CD34'"CD64-M-CSFR'" population in Fig 8A (solid thick line in Fig 9) showed heterogeneous levels of CD34. with a subset remaining CD34'" at 60 hours of culture (to the right of the vertical line in Fig 9) . Furthermore, most of the progeny from the CD34h'CD64-M-CSFR'" cells had higher CD34 levels than the cells expressing CD64 and/or M-CSFR. These results indicate a clear distinction between CD34h' cells with
CD34hi cells
CD34hiCD64-M-CSFR'o.
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DISCUSSION
The present study shows that the M-CSFR is expressed on 44% 2 5% of CD34h' cells, which contain the majority of primitive progenitors and colony-forming cells of the granulo-monocytic lineage. FACS sorting studies showed that the M-CSFR' population corresponded to the M-CSFresponsive cells and that these cells gave rise exclusively to granulo-monocytic colonies. CD34h'CD38"'CD50+ cells were homogeneously negative for the receptor and did not respond to M-CSF, suggesting that primitive progenitor cells are not targets for M-CSF. This finding is in accordance with a report showing a relative absence of M-CSFR mRNA in a population enriched for murine hematopoietic stem cells.29 This result suggests that the effects of M-CSF reported earlier on primitive HPP cells9-" reflect effects on progeny that has differentiated during culture or, alternatively, that the M-CSF-responsive HPP cells are more differentiated than the CD34hiCD3810CD50+ progenitors. An earlier study showed that a population highly enriched for murine gra- The indicated subsets were sorted singly, cultured, and analyzed as described in the legend to Table 1 . The percentages of recovery indicate the number of colonies with phenotypic characteristics of granulocytic (CFU-G), monocytic (CFU-M). or granulo-monocytic (CFU-GM) cells derived from each subset relative to the number of these colonies from the total CD34' population. The numbers represent the average and SD of three individual experiments.
nulo-monocytic progenitors also contains a large proportion of cells expressing mRNA for the M-CSFR. 30 The present study shows that functionally distinct subsets of granulomonocytic progenitors can be isolated on the basis of differential surface expression of the M-CSFR and the granulo-monocytic marker CD64.3.'6 Monocyte progenitors constituted approximately 70% of the CFCs among the CD34h'M-CSFRh' cells, whereas 91% of the CFCs from the CD34h'CD64+M-CSFRl" population were CFU-G (Table 1) . Thus, the present study shows that M-CSFR is useful as a marker of granulo-monocytic lineage commitment and to identify the divide between the pathways leading to granulocyte and monocyte differentiation.
CD64 was previously identified as the earliest specific marker for granulo-monocytic lineage commitment among a large number of candidate molecule^.'^^^' However, several lines of evidence indicate that M-CSFR appears before CD64 during the differentiaton of most monocytic progenitors in the BM. First, 31% of CFU-M were recovered from the CD64-M-CSFRh' subset, whereas only 0.9% were found among the CD64'M-CSFR'" cells (Table 2) . Second, the macrophage colonies formed by cells in the CD64-MCSFRh' population were larger and far more frequent than those derived from the two CD64+ subsets (Table I) . Third, whereas CD64+ monocytic progenitors were expanded maximally by M-CSF alone, monocytic progenitors in the CD64-M-CSFRh' subset could be expanded additionally in the presence of multiple cytokines (Fig 7) . Finally, cells in the CD64-M-CSFRh' population expressed higher levels of CD34 than those that were CD64'. The results in Fig 8C show that a minor subset of CD64+M-CSFR1" cells upregulated the M-CSFR in vitro and formed monocytes. Some of these cells could reflect contamination of the sort gates, as we have earlier shown that there may be a 2% to 6% contamination between erythroid and granulo-monocytic sort On the other hand, studies of in vitro differentiation of primitive progenitors suggest that a substantial fraction of monocytic progenitor cells may regulate CD64 and M-CSF in the opposite order under certain conditions (Fig 8D) . M-CSFR and CD64 may therefore be regulated by the cells environment rather than as part of a fixed intrinsic differentiation program. Whereas a recent study found that only 10% of murine CFU-M were M-CSFR','' our results show that 55% of human CFU-M could be recovered from M-CSFRh' cells. This discrepancy may be species-related or due to differences in the methods used to detect the receptor. In the present study, we found that CD34' cells had to be incubated for several hours in SF medium before the receptor could be detected on the surface of most cells. We cannot exclude the possibility that the upregulation of the M-CSFR under these conditons is due to cellular stress or absence of a negative regulatory pathway due to culture in SF medium. On the other hand, the M-CSFR is highly labile on the surface of monocytic cells and is internalized and digested within 15 minutes after ligand binding. response in CD34+CD64+ cells than SCF during 24 hours, as measured by BrdU incorporation. The results may therefore indicate that M-CSFR is coupled to signaling pathways that are qualitatively or quantitatively distinct from those activated via the SCFR in normal hematopoietic progenitor cells.
Cytokine target specificity can be mediated by at least two mechanisms: regulation of receptor expression and regulation of expression of molecules necessary to transmit signals from the receptor. We have recently shown that receptor distribution is sufficient to explain the specific effect of EPO on erythropoiesis, whereas SCF selectivity is determined in part by cell-type-restricted expression of molecules other than the SCFR.3 In a previous study, forced expression of the M-CSFR into granulocytic progenitors failed to confer M-CSF responsi~eness.~~ This finding may indicate that M-CSF responsiveness depends on cell-type-specific signaling molecules. However, the results from the present study suggest that M-CSFR+ granulocytic progenitors can respond to M-CSF, because M-CSF alone leads to an increase in the number of granulocytic cells from the CD34h'M-CSFRh' population after 5 days of culture. However, the effects of M-CSF on granulocyte development were found to be limited by rapid downmodulation of M-CSFR on granulocytic progenitors shortly after initiation of the culture, as shown in Fig 8. Lineage-dependent receptor regulation can also explain the small increase in the number of monocytic cells obtained after culture of the CD34h'CD64+M-CSFR'" population with M-CSF alone. Monocytic cells within this population upregulated the receptor during the 60 hours of culture. The results showing that these cells were fully expanded in M-CSF alone (Fig 7) suggest that they represent relatively late monocytic progenitors. Our results therefore suggest that regulation of receptor expression is the predominant mechanism for M-CSF selectivity among human hematopoietic progenitor cells. Specificity for monocytic cells seems to be determined partly by induction of the receptor during or after commitment to the monocytic lineage and partly by downmodulation of the receptor during early granulocytic differentiation.
The results showing lineage-dependent regulation of CD64 and M-CSFR during early hematopoietic development are interesting in view of the detailed knowledge about the factors that regulate their expression. The promoters of M-CSFR and CD64 contain stimulatory binding sites for transcription factors of the ets family, including PU.1 .i2.",36, '7 There are also differences in their promoters that may explain the differences in regulation. The CD64 promoter contains an element that binds transcription factors of the STAT family, including those induced by IL-6. Furthermore, the M-CSFR promoter has stimulatory binding sites for additional monocyte-specific factors as well as inhibitory binding sites for c-myb.I2l3 Knockout experiments of PU.l and c-myb have shown essential roles for both factors in hematopoiesis, but it is not clear where in the differentiation process the molecules A recent study on embryonic stem (ES) cells from PU.1 -/-mice showed that PU.l was necessary for differentiation-associated expression of CD64 and M-CSFR.I4 However, in the ES system, these two molecules appeared at the stage of terminal differentiation, several days later than expression of CD14.14 It was therefore concluded that PU.l primarily is important for late steps in monocytic development. In normal BM, CD14 is a late monocytic marker that appears when the cells are CD34-.i63' The results from the present study showing that M-CSFR and CD64 are present on a substantial fraction of CD34h' cells demonstrate that these are early myeloid markers and suggest that PU.1 may be involved at an early stage in hematopoietic development. The results also indicate that care should be taken before extending conclusions from ES cell differentiation systems to BM progenitor cells. In Fig 8, we present a system in which small steps in myeloid differentiation can be studied by sorting homogeneous populations of progenitor cells at distinct stages in maturation and measuring differentiation-associated events during short-term culture. When combined with sensitive methods for detection of gene regulation, such as the reverse transcriptase-polymerase chain reaction, this should be a powerful system to examine events associated with normal hematopoietic development. One
For personal use only. on November 11, 2017. by guest www.bloodjournal.org From question that may be immediately addressed is whether the levels of PU.l are different in the populations and if the expression of this factor changes when the cells differentiate in vitro. This type of experiments may also give the answer to why CD64 and M-CSFR seem to be regulated differently when primitive cells differentiate in vitro.
In conclusion, the present study shows that M-CSF target specificity among human hematopoietic progenitor cells is determined by lineage-specific regulation of the M-CSFR. The M-CSFR is a useful marker to isolate CFU-G and CFU-M and to study early granulo-monocytic differentiation in vitro.
